norelgestromin + ethinyl estradiol

DRUG2 trials

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Janssen Pharmaceutica N.V., Belgium

Conditions

ContraceptionFemale Contraception

Phase 3

A Study of Efficacy and Safety With the Transdermal Contraceptive System.

CompletedNCT00236769

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Contraception, Female Contraception

Start: 1997-11-30End: 1999-10-31Updated: 2010-11-17

Phase 4

Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.

CompletedNCT00261482

Janssen Pharmaceutica N.V., BelgiumContraception, Female Contraception

Start: 2003-07-31End: 2004-12-31Updated: 2010-11-16